1| HOUSE OF REPRESENTATIVES - FLOOR VERSION | | | 2| STATE OF OKLAHOMA | | | 3| 2nd Session of the 59th Legislature (2024) | | | 4|COMMITTEE SUBSTITUTE | |FOR ENGROSSED | 5|SENATE BILL NO. 1296 By: Rosino of the Senate | | | 6| and | | | 7| Newton of the House | | | 8| | | | 9| | | | 10| COMMITTEE SUBSTITUTE | | | 11| An Act relating to the Opioid Overdose Fatality | | Review Board; amending 63 O.S. 2021, Section 2-1002, | 12| which relates to composition and meetings of the | | Board; modifying membership of the Board; modifying | 13| required frequency of meetings; providing an | | effective date; and declaring an emergency. | 14| | | | 15| | | | 16|BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA: | | | 17| SECTION 1. AMENDATORY 63 O.S. 2021, Section 2-1002, is | | | 18|amended to read as follows: | | | 19| Section 2-1002. A. The Opioid Overdose Fatality Review Board | | | 20|shall be composed oftwenty-two (22)eighteen (18) members, or their | | | 21|designees, as follows: | | | 22| 1.TwelveEight of the members shall be: | | | 23| a. the Attorney General or designee, | | | 24| b. the Chief Medical Examiner or designee, | | | arsid3699630 SB1296 HFLR Page 1 ___________________________________________________________________________
1| c.the State Commissioner of Health or designee,| | | 2|d.the Chief of Injury Prevention Services of the State| | | 3|Department of Health or designee,| | | 4|e.the President of the Oklahoma State Medical| | | 5|Association or designee,| | | 6|f.the Director of the Oklahoma State Bureau of | | | 7| Narcotics and Dangerous Drugs Control or designee, | | | 8|g.| | | 9| d. the Commissioner ofthe Department ofMental Health | | | 10| and Substance Abuse Services or designee, | | | 11|h.the President of the Oklahoma Osteopathic Association| | | 12|or designee,| | | 13|i.| | | 14|e. the Director of the Department of Human Services or | | | 15| designee, | | | 16|j.| | | 17|f. the Director of the Oklahoma State Bureau of | | | 18| Investigation or designee,| | | 19|k.| | | 20|g. the President of the Association of Oklahoma Narcotic | | | 21| Enforcers or designee, and | | | 22|l.| | | 23|h. the Executive Director of the State Board of Pharmacy | | | 24| or designee; and | | | arsid3699630 SB1296 HFLR Page 2 ___________________________________________________________________________
1| 2. Ten of the members shall be appointed by the Attorney | | | 2|General, shall serve for terms of two (2) years and shall be | | | 3|eligible for reappointment. The members shall be persons having | | | 4|training and experience in matters related to opioid abuse and | | | 5|prevention. The appointed members shall include: | | | 6| a. a county sheriff selected from a list of three names | | | 7| submitted by the executive board of the Oklahoma | | | 8| Sheriffs' Association, | | | 9| b. a chief of a municipal police department selected | | | 10| from a list of three names submitted by the Oklahoma | | | 11| Association of Chiefs of Police, | | | 12| c. an attorney licensed in this state who is in private | | | 13| practice selected from a list of three names submitted | | | 14| by the Board of Governors of the Oklahoma Bar | | | 15| Association, | | | 16| d. a district attorney selected from a list of three | | | 17| names submitted by the District Attorneys Council, | | | 18| e. a physician with emergency medical training selected | | | 19| from a list of three names submitted by the Oklahoma | | | 20| State Medical Association, | | | 21| f. a physician with experience in drug addiction | | | 22| treatment and recovery selected from a list of three | | | 23| names submitted by the Oklahoma Osteopathic | | | 24| Association, | | | arsid3699630 SB1296 HFLR Page 3 ___________________________________________________________________________
1| g. a nurse selected from a list of three names submitted | | | 2| by the Oklahoma Nurses Association, | | | 3| h. two individuals, at least one of whom shall be a | | | 4| person who currently receives or formerly has been a | | | 5| consumer of addiction recovery services related to | | | 6| opioid use, selected from a list of three names | | | 7| submitted by the Department of Mental Health and | | | 8| Substance Abuse Services, and | | | 9| i. a member of the judiciary selected from a list of | | | 10| three names submitted by the Oklahoma Supreme Court. | | | 11| B. Every two (2) years the Board shall elect from among its | | | 12|membership a chair and avice-chairvice chair. The Board shall | | | 13|meetat least quarterly and may meet moreas frequently as necessary | | | 14|as determined by the chair. Members shall serve without | | | 15|compensation but may be reimbursed for necessary travel out of funds | | | 16|available to the Office of the Attorney General and the Department | | | 17|of Mental Health and Substance Abuse Services pursuant to the State | | | 18|Travel Reimbursement Act; provided, that the reimbursement shall be | | | 19|paid, in the case of state employee members, by the agency employing | | | 20|the member. | | | 21| C. With funds appropriated or otherwise available for that | | | 22|purpose, the Office of the Attorney General, jointly with the | | | 23|Department of Mental Health and Substance Abuse Services, shall | | | 24| | | | arsid3699630 SB1296 HFLR Page 4 ___________________________________________________________________________
1|provide administrative assistance and services to the Opioid | | | 2|Overdose Fatality Review Board. | | | 3| SECTION 2. This act shall become effective July 1, 2024. | | | 4| SECTION 3. It being immediately necessary for the preservation | | | 5|of the public peace, health or safety, an emergency is hereby | | | 6|declared to exist, by reason whereof this act shall take effect and | | | 7|be in full force from and after its passage and approval. | | | 8| | | | 9|COMMITTEE REPORT BY: COMMITTEE ON GENERAL GOVERNMENT, dated | |04/10/2024 - DO PASS, As Amended. | 10| | | | 11| | | | 12| | | | 13| | | | 14| | | | 15| | | | 16| | | | 17| | | | 18| | | | 19| | | | 20| | | | 21| | | | 22| | | | 23| | | | 24| | | | arsid3699630 SB1296 HFLR Page 5